Winterlight Labs Patents

Patent portfolio assigned to Winterlight Labs (verified via public assignee records). Estimated patent count: 20. Toronto speech-based digital biomarker company for cognitive impairment/dementia; acquired by Cambridge Cognition (Jan 2023). Genentech collaboration and academic/institutional partners listed on site. GreyB reports 20 patents globally (4 granted). 'Trusted by 5 of top 10 life sciences companies' is unnamed, so not listed.